News Continuing Multiple Sclerosis Education To Be Offered at AIMS Live Meetings Continuing Multiple Sclerosis Education To Be Offered at AIMS Live Meetings by Patricia Silva, PhD | September 26, 2014 Share this article: Share article via email Copy article link With multiple sclerosis (MS) prevalence rates still at concerning levels of 90 for every 100,000 Americans, researchers are continuously seeking to learn more about the disease, and are aggressively working to develop novel treatments and interventions for symptom management. This poses an ongoing challenge for healthcare professionals and academics, as it may be difficult for them to remain up to speed on the latest research updates and medical best practices for treating MS. Thanks to three multinational organizations’ efforts, however, more medical professionals and educators will be able to implement and help disseminate the latest updates on Multiple Sclerosis. The France Foundation, The Consortium of Multiple Sclerosis Centers (CMSC), and Nurse Practitioner Alternatives (NPA) have teamed up to launch a comprehensive program of study to educate healthcare providers on MS updates. Advances in Multiple Sclerosis (AIMS) provides free continuing education credits through either live or on-demand opportunities. [adrotate group=”4″] One of AIMS’ upcoming live learning meetings is scheduled Saturday, October 11, at the Marriott World Center in Orlando, FL. A second AIMS live meeting will take place on Saturday, November 22 at the Omni New Haven Hotel in New Haven, CT, which will feature opening remarks fromĀ David A. Hafler, MD, and Gilbert H. Glaser, a Professor of Neurology and Immunobiology, and Chairman of the Department of Neurology at Yale School of Medicine.Ā All of the meetings sessions are free, and will include the following topics: Updates on Developments in Multiple Sclerosis: Immunopathology and MRI Updates on the Current and Emerging Treatments for Multiple Sclerosis Comprehensive Care in MS: Improving Communication and Coordination Among the Multidisciplinary Team During these live meetings, attendees will also have engaging, open forums with invited experts on MS, such as: Joseph R. Berger, MD (Chair), Professor of Neurology and Chief of the MS Division, Perelman School of Medicine, University of Pennsylvania Guy J. Buckle, MD, Director of Neuroimaging Research, Shepherd Center Marie Namey, RN, MSN, MSCN Clinical Nurse Specialist, Mellen Center for MS Treatment & Research, The Cleveland Clinic While these meetings are complementary, AIMS encourages attendees to register. To those interested in accessing the organization’s other free educational services, such as webinars, podcasts, references, etc., visitĀ https://www.cmeaims.org. For specialized resource materials for professionals and researchers, visitĀ https://www.cmscscholar.org. One of the more intriguing clinical updates that the MS community may soon learn about via a continuing education effort such as AIMS is a dendtritic cell vaccine against MS. Scientists from theĀ Baylor Institute for Immunology Research are currently studying the possibility of an MS treatment that will not only help fight off the disease, but preserve the immune system as well. Print This Page About the Author Patricia Silva, PhD PatrĆcia holds a PhD in medical microbiology and infectious diseases from the Leiden University Medical Center, Netherlands, and completed a postdoctoral research fellowship at the Instituto de Medicina Molecular, Lisbon, Portugal. Her work in academia was mainly focused on molecular biology and the genetic traits of infectious agents such as viruses and parasites. PatrĆcia earned several travel awards to present her work at international scientific meetings. She is a published author of several peer-reviewed science articles. Tags conference, Consortium of Multiple Sclerosis Centers
April 26, 2024 News by Margarida Maia, PhD Employment, income drop steadily over 2 decades after onset of MS
April 26, 2024 News by Marisa Wexler, MS Machine learning model predicts CIS to MS conversion risk: Study
April 25, 2024 Columns by Benjamin Hofmeister Finding safety while living with the constant threat of MS progression